Landgren, O. Et Al. 2025. Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS. Blood .

Landgren, O., Chari, A., Cohen, Y. C., Spencer, A., Voorhees, P. M., Sandhu, I., ... Jenner, M. W.(2025). Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS. Blood .

Landgren, Ola Et Al. "Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS," Blood , 2025

Landgren, Ola Et Al. "Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS." Blood , 2025

Landgren, O. Et Al. (2025) . "Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS." Blood .

@article{article, author={Ola Landgren Et Al. }, title={Efficacy and safety of daratumumab in intermediate/high-risk smoldering multiple myeloma: final analysis of CENTAURUS}, journal={Blood}, year=2025}